Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:854-861
Published online before print September 10, 2007, doi: 10.1161/HYPERTENSIONAHA.107.092650
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
50/5/854    most recent
HYPERTENSIONAHA.107.092650v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow patientINFORMation
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Margolis, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Margolis, K. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMLODIPINE BESYLATE
*ATENOLOL
*CHLORTHALIDONE
*CLONIDINE
*DOXAZOSIN MESYLATE
*HYDRALAZINE HYDROCHLORIDE
*LISINOPRIL
*RESERPINE
Medline Plus Health Information
*Blood Pressure Medicines
*Heart Disease in Women
*Heart Diseases
*High Blood Pressure
*Hispanic-American Health
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Clinical Studies
Right arrow Epidemiology

(Hypertension. 2007;50:854.)
© 2007 American Heart Association, Inc.


Original Articles

Blood Pressure Control in Hispanics in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Karen L. Margolis; Linda B. Piller; Charles E. Ford; Mario A. Henriquez; William C. Cushman; Paula T. Einhorn; Pedro J. Colon, Sr; Donald G. Vidt; Rudell Christian; Nathan D. Wong; Jackson T. Wright, Jr; David C. Goff, Jr for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group

From the HealthPartners Research Foundation (K.L.M.), Minneapolis, Minn; School of Public Health (L.B.P., C.E.F.), University of Texas Health Science Center, Houston; Bronx Nephrology Hypertension (M.A.H.), Bronx, NY; Research and Development Service, Memphis Veterans Affairs Medical Center (W.C.C.), Tenn; National Heart, Lung, and Blood Institute (P.T.E.), Bethesda, Md; Centro Cardiovascular de Caguas (P.J.C.), Caguas, Puerto Rico; Cleveland Clinic (D.G.V.), Ohio; NitroMed (R.C.), Lexington, Mass; Heart Disease Program, University of California at Irvine (N.D.W.); Case Western Reserve University (J.T.W.), Cleveland, Ohio; and Department of Epidemiology and Prevention, Wake Forest University School of Medicine (D.C.G.), Winston-Salem, NC.

Correspondence to Karen L. Margolis, HealthPartners Research Foundation PO Box 1524, Mailstop 21111R, Minneapolis, MN 55440-1524. E-mail Karen.L.Margolis{at}HealthPartners.com

Historically, blood pressure control in Hispanics has been considerably less than that of non-Hispanic whites and blacks. We compared determinants of blood pressure control among Hispanic white, Hispanic black, non-Hispanic white, and non-Hispanic black participants (N=32 642) during follow-up in a randomized, practice-based, active-controlled trial. Hispanic blacks and whites represented 3% and 16% of the cohort, respectively; 33% were non-Hispanic black and 48% were non-Hispanic white. Hispanics were less likely to be controlled (<140/90 mm Hg) at enrollment, but within 6 to 12 months of follow-up, Hispanics had a greater proportion <140/90 mm Hg compared with non-Hispanics. At 4 years of follow-up, blood pressure was controlled in 72% of Hispanic whites, 69% of Hispanic blacks, 67% of non-Hispanic whites, and 59% of non-Hispanic blacks. Compared with non-Hispanic whites, Hispanic whites had a 20% greater odds of achieving BP control by 2 years of follow-up (odds ratio: 1.20; 95% CI: 1.10 to 1.31) after controlling for demographic variables and comorbidities, Hispanic blacks had a similar odds of achieving BP control (odds ratio: 1.04; 95% CI: 0.86 to 1.25), and non-Hispanic blacks had a 27% lower odds (odds ratio: 0.73; 95% CI: 0.69 to 0.78). We conclude that in all patients high levels of blood pressure control can be achieved with commonly available medications and that Hispanic ethnicity is not associated with inferior control in the setting of a clinical trial in which hypertensive patients had equal access to medical care, and medication was provided at no cost.


Key Words: hypertension • Hispanic • ethnicity • race • clinical trials • blood pressure control


Find additional patient-related information at:

Blood Pressure Control in Hispanics in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial


This article has been cited by other articles:


Home page
Circ Cardiovasc Qual OutcomesHome page
P. T. Einhorn
National Heart, Lung, and Blood Institute-Initiated Program "Interventions to Improve Hypertension Control Rates in African Americans": Background and Implementation
Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 236 - 240.
[Full Text] [PDF]